SCHEMBL29447377

SCHEMBL29447377

COc1ccc(CN(c2nccs2)S(=O)(=O)c2ccc(N[C@H]3CCN(C(=O)OC(C)(C)C)C3)c(Cl)c2)c(OC)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.41
STS P08842 2/20 0.39
SCN8A Q9UQD0 5/20 0.38
SCN1A P35498 4/20 0.38
DYRK1A Q13627 1/20 0.38
SCN5A Q14524 1/20 0.38
ALDH1A1 P00352 1/20 0.37
PIK3CA P42336 1/20 0.37
BMP1 P13497 1/20 0.37
MMP1 P03956 1/20 0.37
MMP3 P08254 1/20 0.37
MMP7 P09237 1/20 0.37
MMP9 P14780 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
SLC2A1 P11166 1/20 0.36
USP30 Q70CQ3 1/20 0.36
PIK3CD O00329 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19631557 1.00 CNR1 (0.41) CNR1STSSCN8ASCN1ADYRK1A
SCHEMBL29447346 1.00 CNR1 (0.41) CNR1STSSCN8ASCN1ADYRK1A
SCHEMBL19631765 1.00 CNR1 (0.41) CNR1STSSCN8ASCN1ADYRK1A
SCHEMBL19614233 0.95 SCN8A (0.37) CNR1STSSCN8ASCN1ADYRK1A
SCHEMBL19627633 0.94 CNR1 (0.41) CNR1STSSCN8ASCN1ADYRK1A
SCHEMBL19627609 0.94 CNR1 (0.41) CNR1STSSCN8ASCN1ADYRK1A
SCHEMBL19613952 0.92 SCN8A (0.42) SCN8ASCN1ASCN5ANPC1RAB9A
SCHEMBL19613657 0.92 SCN8A (0.42) SCN8ASCN1ASCN5ANPC1RAB9A
SCHEMBL19613655 0.92 SCN8A (0.42) SCN8ASCN1ASCN5ANPC1RAB9A
SCHEMBL19631669 0.90 STS (0.39) STSSCN8ASCN1ADYRK1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11299490-B2 Benzenesulfonamide compounds and their use as therapeutic agents XENON PHARMACEUTICALS INC. (CA) 2022-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11299490-B2 Benzenesulfonamide compounds and their use as therapeutic agents SCN1A, SCN1B, SCN2B CNR1 445/4885STS 181/4885SCN8A 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.